Latest filing published 10 Sept 2026 for SOPHiA GENETICS SA, €44k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kathy l. Hibbs (senior executive) discloses dealings in 3 companies, chiefly 23andMe Holding Co., Standard Biotools Inc. and SOPHiA GENETICS SA. Between 6 January 2022 and 8 September 2026, the trades on record add up to 43 filings.
Sales make up the whole of the open-market record (3 sales, €171k). Besides market trades, the filings include 16 share grants and 24 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 10 September 2026, reports an open-market sale of €44k in SOPHiA GENETICS SA. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations